PubMed · 12423599
Vancomycin encapsulation in biodegradable poly(epsilon-caprolactone) microparticles for bone implantation. Influence of the formulation process on size, drug loading, in vitro release and cytocompatibility.
Abstract
Vancomycin encapsulation in biodegradable poly(epsilon-caprolactone) microparticles (200 microm mean diameter) was most efficient with a simple emulsion technique that dispersed 122.5 mg/g of polymer. Scanning electron micrographs showed smooth or pitted particles. Dissolution studies were correlated with microparticle morphology, indicating higher release with pitted particles when vancomycin was encapsulated in a dissolved state. The cytocompatibility of these poly(epsilon-caprolactone) microparticles was demonstrated by a direct contact cytotoxic assay. This material can be considered as an efficient drug delivery system for bone implantation.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
A-M Le Ray, S Chiffoleau, P Iooss, G Grimandi, A Gouyette, G Daculsi, C Merle. 2003. Vancomycin encapsulation in biodegradable poly(epsilon-caprolactone) microparticles for bone implantation. Influence of the formulation process on size, drug loading, in vitro release and cytocompatibility.. https://doi.org/10.1016/s0142-9612(02)00357-5. https://pubmed.health/record/pubmed%3A12423599/vancomycin-encapsulation-in-biodegradable-poly-epsilon-caprolactone-microparticles-for-bone-implanta
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.